Efficacy and tolerability of Janus kinase inhibitors in myelofibrosis: a systematic review and network meta-analysis

Myelofibrosis is a myeloproliferative neoplasm associated with constitutional symptoms, increasing splenomegaly, and worsening cytopenias. Janus kinase (JAK) inhibitors have been used for the treatment of myelofibrosis for several years, but there is a lack of comparative information between those t...

Descripción completa

Detalles Bibliográficos
Autores principales: Sureau, Léa, Orvain, Corentin, Ianotto, Jean-Christophe, Ugo, Valérie, Kiladjian, Jean-Jacques, Luque Paz, Damien, Riou, Jérémie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316412/
https://www.ncbi.nlm.nih.gov/pubmed/34315858
http://dx.doi.org/10.1038/s41408-021-00526-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316412/
https://www.ncbi.nlm.nih.gov/pubmed/34315858
http://dx.doi.org/10.1038/s41408-021-00526-z

Ejemplares similares